Integer Holdings Reports as KKR Deal Nears Close

Integer Holdings is a medical device contract manufacturer scheduled to report Q3 results today, but the earnings number is almost secondary to the deal mechanics now reshaping the stock's register.

KKR filed a Schedule 13D on October 13, disclosing a 14% stake under the entity Tarheel Investors III L.P. That filing is an activist disclosure, the most significant event-type in the SEC register, and it arrived alongside news of an agreed cash acquisition. The institutional picture has shifted accordingly: KKR now appears as the second-largest reported holder at 4.75 million shares, just behind BlackRock's 5.35 million. ORTEX forecasts an 84% probability that Integer will be deleted from both the Russell 2000 and Russell 3000 in connection with the takeover, with a trade date estimated around October 27 and effective date October 28. In 351 comparable deletions driven by cash acquisitions, the median move from announcement to effective was minus 4.3%, with trade-day volume running at 9.1 times normal. That is history, not a prediction, but index trackers will need to unwind mandatory positions regardless of what the print contains.

Short interest at 8.2% of the free float is meaningful for a name this deep into announced-deal territory, though it has eased roughly 2.6% over the past week after a brief spike to around 3.1 million shares on October 13, the same day the 13D landed. The borrow market offers no sign of stress: availability is running at 1,524%, meaning shares available to lend outnumber the short book by a factor of fifteen, and cost to borrow has retreated from a mid-October peak of 0.95% to 0.49%. Options positioning has moved in the same session: the put/call ratio reached 0.054 on October 21, three standard deviations above its 20-day average of 0.037. That is an elevated reading in absolute terms, though the ratio itself remains well below 1.0, so it speaks more to a recent shift in hedging demand than to outright bearish conviction.

The analyst community was largely negative after the last print. Benchmark, Oppenheimer, Truist Securities, and Freedom Capital Markets all downgraded the stock in early August, leaving nine holds and zero buys in the current consensus. The mean price target from that period was $121.80, below where the stock trades today at $126.70, though those targets are now over two months old and were set before the KKR deal crystallised. The bear case centres on a third-quarter revenue estimate of roughly $450.5 million, down about 3.7% year over year, with adjusted EPS expected to fall from $1.79 to $1.63. Margin pressure from operational investments and reduced guidance following customer forecast resets are the specific concerns. The bull case rests on the strategic review and inbound acquisition interest signalling that the market was undervaluing the franchise, an argument now partially resolved by the deal itself. Net insider selling of roughly $5.2 million over the 90 days to mid-September, led by the Chief Human Resources Officer and the President of Growth and Innovation in open-market sales, added a cautionary note in the weeks before the takeover announcement.

With an agreed acquisition on the table, today's print is less a test of whether Integer can recover its revenue trajectory and more a question of whether any detail in the Q3 numbers, or the management commentary around the KKR transaction, alters the timeline or terms that the market is now pricing.